This eventually masked the impact of immune escape in RE tumours, as expression of checkpoint molecules CD274 (PD-L1; programmed cell death ligand 1) and CD152 (CTLA-4; cytotoxic T-lymphocyte-associated protein 4) were found to be markedly increased at baseline levels. Here, CTLA4 is linked to neoplasm.